Centiva Capital, LP Vericel Corp Transaction History

Centiva Capital, LP

  • $4.79 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$23.85 - $31.34 $266,476 - $350,161
11,173 New
11,173 $327,000
Q3 2021

Nov 15, 2021
SELL
$46.35 - $59.75 $352,769 - $454,757
-7,611 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$47.2 - $67.81 $359,239 - $516,101
7,611 New
7,611 $400,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.5M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email